美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Viela Bio

53.01

0.0000

成交量：- -

成交額：- -

市值：29.13億

市盈率：-18.70

高：53.01

開：53.01

低：53.01

收：53.01

52周最高：65.00

52周最低：25.02

股本：5,495.01萬

流通股本：2,290.57萬

量比：- -

換手率：- -

股息：- -

股息率：- -

每股收益(TTM):-2.8345

每股收益(LYR):-2.8345

淨資產收益率：-41.26%

總資產收益率：-23.83%

市淨率：7.75

市盈率(LYR):-18.70

資料載入中...

總覽公司新聞資訊公告

公司資料

公司名字：

Viela Bio

交易所：

NASDAQ

成立時間：

- -

員工人數：

- -

公司地址：

- -

官網：

http://www.vielabio.com

郵編：

- -

電話：

- -

傳真：

- -

簡介：

Viela Bio, Inc.於2017年12月11日根據特拉華州法律註冊成立。該公司是一家臨床階段的生物技術公司，開創了自身免疫和嚴重炎症性疾病的治療方法，該公司統稱為自身免疫性疾病。他們的方法旨在通過關注多種疾病共有的關鍵生物學途徑，重新定義自身免疫性疾病的治療方法。

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/VIE/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"VIE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VIE\",,,,,undefined,":{"symbol":"VIE","market":"US","secType":"STK","nameCN":"Viela Bio","latestPrice":53.01,"timestamp":1615582800000,"preClose":53.01,"halted":3,"volume":0,"delay":0,"changeRate":0,"floatShares":22905711,"shares":54950149,"eps":-2.834497,"marketStatus":"停牌","change":0,"latestTime":"03-12 16:00:00 EST","open":53.01,"high":53.01,"low":53.01,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.834497,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1774252800000},"marketStatusCode":7,"adr":0,"listingDate":1570075200000,"exchange":"NASDAQ","adjPreClose":53.01,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VIE\",,,,,undefined,":{"symbol":"VIE","floatShares":22905711,"roa":"-23.83%","roe":"-41.26%","lyrEps":-2.834497,"shares":54950149,"dividePrice":0,"high":53.01,"amplitude":0,"preClose":53.01,"low":53.01,"week52Low":25.02,"pbRate":"7.75","week52High":64.9999,"institutionHeld":0,"latestPrice":53.01,"eps":-2.834497,"divideRate":0,"volume":0,"delay":0,"ttmEps":-2.834497,"open":53.01,"prevYearClose":35.97},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/VIE\",params:#limit:5,,,undefined,":[{"market":"US","date":"2021-03-16","symbol":"VIE","reason":null,"defaultRemindTime":1615901400000,"announcedDate":"2021-03-09","type":"delisting","dateTimestamp":1615867200000},{"market":"US","date":"2021-03-01","symbol":"VIE","fiscalQuarterEnding":"2020/12","expectedEps":-0.72,"name":null,"time":"盤後","type":"earning","dateTimestamp":1614574800000,"reportTimeType":"post","actualEps":-0.6},{"market":"US","date":"2020-11-10","symbol":"VIE","fiscalQuarterEnding":"2020/09","expectedEps":-0.77,"name":null,"time":"","type":"earning","dateTimestamp":1604984400000,"reportTimeType":"","actualEps":65},{"date":"2020-08-12","symbol":"VIE","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2020/06","expectedEps":-1.03,"defaultRemindTime":1597262400000,"name":null,"time":"盤後","dateTimestamp":1597204800000,"actualEps":null},{"date":"2020-05-13","symbol":"VIE","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2020/03","expectedEps":-0.69,"defaultRemindTime":1589400000000,"name":null,"time":"盤後","dateTimestamp":1589342400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"VIE\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"VIE\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/VIE\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"VIE","date":"2021-03-12","current":-18.701731,"percent":0.437853,"low":-30.538807,"twenty":-23.315344,"median":-18.559006,"eighty":-14.736618,"high":-9.987485,"avg":-18.964097,"sd":4.784643,"marketCap":2912907398},"quantilePoints":[],"updateTime":1774142570612},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.vielabio.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":-0.0207},{"period":"1month","weight":-0.055},{"period":"3month","weight":-0.047},{"period":"6month","weight":-0.0228},{"period":"1year","weight":0.1469},{"period":"ytd","weight":-0.0489}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"Viela Bio, Inc.於2017年12月11日根據特拉華州法律註冊成立。該公司是一家臨床階段的生物技術公司，開創了自身免疫和嚴重炎症性疾病的治療方法，該公司統稱為自身免疫性疾病。他們的方法旨在通過關注多種疾病共有的關鍵生物學途徑，重新定義自身免疫性疾病的治療方法。","exchange":"NASDAQ","name":"Viela Bio","nameEN":"Viela Bio"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"VIE\",market:\"US\",,,undefined,":null}}